Atlas Trials

Clinical Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patients With Refractory Cirrhotic Ascites

Clinical trial NCT06919523 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06919523
Sponsor
Mansoura University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Refractory Ascites
Start date
2025-04-15
Primary completion
2025-08-15
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.